All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma
Journal for ImmunoTherapy of Cancer · 2023
DOI: 10.1136/jitc-2022-006325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2023. Verfasst von Ziyi Peng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Multiple Myeloma. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Guangci Translational Medicine Research Foundation, National Natural Science Foundation of China, Beijing Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Immunotherapies targeting CD38 have demonstrated salient efficacy in relapsed/refractory multiple myeloma (MM). However, loss of CD38 antigen and outgrowth of CD38 negative plasma cells have emerged as a major obstacle in clinics. All-trans retinoic acid (ATRA) has been reported to upregulate CD38 expression, but the mechanism and adaptive genetic background remain unexplored.
Methods
The efficacy of ATRA in upregulating CD38 expression in MM cells is evaluated by flow cytometry. The interaction between NSD2 and the RARα is analyzed by immunoprecipitation, and the nuclear condensation of RARα is evaluated under laser confocal microscope. A graft model of MM is established in NOD. Cg-Prkdc scid Il2rg tm1Wjl /SzJ mice, and the tumor burden is assessed by in vivo fluorescence imaging.
Results
We report that ATRA upregulates MM cells CD38 in a non-linear manner, which is t(4;14) translocation dependent, and t(4;14) translocation-induced NSD2 shows positive correlation with ATRA-induced level of, but not with basal level of CD38 expression. Mechanistically, NSD2 interacts with the ATRA receptor, RARα, and protects it from degradation. Meanwhile, NSD2 enhances the nuclear condensation of RARα and modifies the histone H3 dimethylation at lysine 36 on CD38 promoter. Knockdown of NSD2 attenuates the sensitization of MM against ATRA induced CD38 upregulation. Translationally, ATRA is prone to augment the efficacy of anti-CD38 CAR T cells in NSD2 high MM cells in vitro and in vivo.
Conclusion
This study elucidates a mechanism of ATRA in regulating CD38 expression and expands the clinical potential of ATRA in improving immunotherapies against CD38 in patients with MM.Cite Now
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.
- Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.
- Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.
- School of Stomatology, Tianjin Medical University, Tianjin, China.
- School of Medicine, Shanghai Jiao Tong University, Shanghai, China zhiqiangliu@tmu.edu.cn jianqingmi@shsmu.edu.cn.
- Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China zhiqiangliu@tmu.edu.cn jianqingmi@shsmu.edu.cn.
ORCID-Profile: Zhiqiang Liu
Förderung
- Shanghai Guangci Translational Medicine Research Foundation
- National Natural Science Foundation of China
- Beijing Natural Science Foundation of China
Zitieren
APA
Peng, Z., Wang, J., Guo, J., Li, X., Wang, S., Xie, Y., Jiang, H., Wang, Y., Wang, M., Hu, M., Li, Q., Wang, Y., Mi, J. Q., & Liu, Z. (2023). All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2022-006325
Vancouver
Peng Z, Wang J, Guo J, Li X, Wang S, Xie Y, et al. All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma. Journal for ImmunoTherapy of Cancer. 2023. doi:10.1136/jitc-2022-006325
BibTeX
@article{Peng2023,
author = {Peng, Ziyi and Wang, Jingya and Guo, Jing and Li, Xin and Wang, Sheng and Xie, Ying and Jiang, Hongmei and Wang, Yixuan and Wang, Mengqi and Hu, Meilin and Li, Qian and Wang, Yafei and Mi, Jian-Qing and Liu, Zhiqiang},
title = {All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2023},
doi = {10.1136/jitc-2022-006325}
}
EUVIMED